OTCMKTS:WUXAY WuXi AppTec (WUXAY) Stock Price, News & Analysis → Start loving Mondays like this (From DTI) (Ad) Free WUXAY Stock Alerts $4.52 0.00 (0.00%) (As of 04/18/2024 ET) Add Compare Share Share Today's Range$4.36▼$4.5250-Day Range$4.10▼$6.9252-Week Range$4.10▼$13.02Volume1,557 shsAverage Volume15,810 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get WuXi AppTec alerts: Email Address Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. About WuXi AppTec Stock (OTCMKTS:WUXAY)WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.Read More WUXAY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WUXAY Stock News HeadlinesApril 15, 2024 | nytimes.comChinese Company Under Congressional Scrutiny Makes Key U.S. DrugsApril 11, 2024 | msn.comUS crackdown on China biotechnology firms causes jitters for Western clientsApril 18, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.April 11, 2024 | americanbankingnews.comShort Interest in WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Rises By 165.4%March 28, 2024 | msn.comUS Says WuXi Sends Intellectual Property to China, Reuters ReportsMarch 28, 2024 | reuters.comExclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told senatorsMarch 25, 2024 | yahoo.comWuXi Bio, AppTec Jump as Biosecure Act Leader Quits CongressMarch 19, 2024 | finance.yahoo.comWuXi Biologics Options See Frenzy Amid US Policy UncertaintyApril 18, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.March 18, 2024 | msn.comWuXi AppTec’s US Sales Rise as Congress Weighs a Federal BanMarch 15, 2024 | msn.comChina stocks close lower; Wuxi Apptec drags down Hong Kong sharesMarch 14, 2024 | msn.comCongressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech ExodusMarch 13, 2024 | ca.finance.yahoo.comBiotech trade association to split with China's WuXi AppTecMarch 12, 2024 | msn.comHong Kong Stocks: WuXi AppTec Shares Surge on Buyback NewsMarch 7, 2024 | msn.comTime to ‘cut off’ US outbound investment in China biotech firms like BGI Group and Wuxi AppTec: House panelMarch 7, 2024 | msn.comChina’s Wuxi AppTec, Biologics, tumble as US sanctions threat growsMarch 7, 2024 | msn.comWuXi Companies’ Shares Fall Amid Renewed U.S. Sanction ConcernsMarch 6, 2024 | msn.comUS Senate bill targeting China's BGI, WuXi AppTec moves forwardMarch 6, 2024 | reuters.comUS Senate committee takes up bill targeting China's BGI, WuXi ApptecMarch 6, 2024 | reuters.comUS Senate committee takes up bill targeting China's BGI, WuXi ApptecFebruary 18, 2024 | reuters.comChina's WuXi AppTec says it poses no national security risks to USJuly 19, 2023 | msn.comWuXi Biologics Hatches New Baby With ADC Drug Unit IPOJuly 10, 2023 | finance.yahoo.comAcasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON Pivotal Phase 3 Safety Trial for GTX-104 in aSAH PatientsMay 26, 2023 | wsj.comWuXi AppTec Co. Ltd. ADRApril 25, 2023 | marketwatch.comWuXi AppTec Shares Slide After First-Quarter Softer Profit GrowthApril 10, 2023 | marketwatch.comPharmaceutical Testing and Analytical Services Market Insights-Industry Changing Aspects, New Technologies and Forecast to 2030April 7, 2023 | marketwatch.comA Closer Look at the Patient Derived Xenograft or PDX Models Market (2023 to 2030)-Opportunities and ChallengesSee More Headlines Receive WUXAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:WUXAY CUSIPN/A CIKN/A Webwww.wuxiapptec.com Phone862120663091FaxN/AEmployees41,116Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 57)Co-Founder, Chairman, President & CEO Dr. Minzhang Chen Ph.D. (Age 55)Co-CEO & Executive Director Dr. Qing Yang Ph.D. (Age 55)Co-CEO & Executive Director Dr. Edward Hu M.B.A. (Age 62)Vice Chairman of the Board & Global Chief Investment Officer Ms. Ming Shi (Age 50)Senior VP & CFO Mr. Zhaohui Zhang (Age 55)COO of China, VP & Executive Director Mr. Yuanzhou Zhang (Age 36)Joint Company Secretary Mr. Ruijia TangIR DirectorDr. Howard Wu J.D.Senior VP, General Counsel & Global Head of Human ResourcesDr. Jingchao Dong Ph.D.Senior VP & Head of RCSMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWDiaSorinOTCMKTS:DSRLFEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHView All Competitors WUXAY Stock Analysis - Frequently Asked Questions How have WUXAY shares performed in 2024? WuXi AppTec's stock was trading at $10.1450 on January 1st, 2024. Since then, WUXAY stock has decreased by 55.4% and is now trading at $4.52. View the best growth stocks for 2024 here. Are investors shorting WuXi AppTec? WuXi AppTec saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 6,900 shares, an increase of 165.4% from the March 15th total of 2,600 shares. Based on an average daily trading volume, of 16,600 shares, the short-interest ratio is presently 0.4 days. View WuXi AppTec's Short Interest. How do I buy shares of WuXi AppTec? Shares of WUXAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:WUXAY) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi AppTec Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.